188 studies found for:    Emtricitabina/ Fumarato de disoproxilo de tenofovir OR Truvada[TREATMENT] AND HIV [CONDITION]
Show Display Options
Rank Status Study
21 Completed Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: raltegravir plus truvada;   Drug: Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)
22 Not yet recruiting Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India
Condition: HIV Infection
Intervention: Drug: Truvada
23 Recruiting Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Condition: HIV-1
Interventions: Drug: Doravirine;   Drug: Darunavir;   Drug: Ritonavir;   Drug: TRUVADA™ or EPZICOM™/KIVEXA™
24 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
25 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
26 Completed Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
Condition: HIV Infections
Interventions: Drug: Truvada;   Drug: Atazanavir;   Drug: Ritonavir
27 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
28 Recruiting PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Have Sex With Men-5
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: Tenofovir/emtricitabine
29 Completed Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
Conditions: Hepatitis B;   HIV Infections
Interventions: Drug: TRUVADA (EMTRICITABINE + TENOFOVIR DF);   Biological: PEGASYS 180μg (Interféron pégylé alpha -2a)
30 Completed GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
Condition: HIV Infections
Interventions: Drug: Truvada (TDF+FTC) alone;   Drug: FTC alone;   Procedure: No HAART
31 Completed
Has Results
Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF);   Drug: abacavir (ABC)/lamivudine (3TC)
32 Completed Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
Condition: HIV Infections
Interventions: Drug: Tenofovir/Emtricitabine (Truvada) and Nevirapine;   Drug: Tenofovir/Emtricitabine/Efavirenz (Atripla);   Drug: Tenofovir (Viread) and Lopinavir/Ritonavir (Aluvia);   Drug: Tenofovir/Emtricitabine (Truvada) and Zidovudine
33 Completed Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)
Condition: HIV Infections
Interventions: Drug: Zidovudine and Lamivudine (Combivir);   Drug: Emtricitabine and Tenofovir (Truvada)
34 Completed
Has Results
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV/r + FTC/TDF
35 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
36 Completed
Has Results
A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines
Condition: Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC278 25 mg;   Drug: TMC278 75 mg;   Drug: TMC278 150 mg;   Drug: Efavirenz;   Drug: Non-nucleoside reverse transcriptase inhibitor (NRTIs)
37 Completed Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
38 Recruiting PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
Condition: HIV
Interventions: Drug: Truvada;   Device: Gel lubricant
39 Terminated
Has Results
Artery Elasticity After Switch From Epzicom to Truvada
Condition: HIV Infections
Intervention: Drug: Tenofovir disoproxil
40 Terminated
Has Results
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
Condition: HIV
Interventions: Drug: Comparator: Raltegravir 400 mg b.i.d.;   Drug: Experimental: Raltegravir 800 mg q.d.;   Drug: TRUVADA™

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years